β1 integrins modulate β-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling

Hypertension

Volumn 49, Issue 4, 2007, Pages 865-872

  Krishnamurthy, Prasanna ^a   Subramanian, Venkateswaran ^a   Singh, Mahipal ^a   Singh, Krishna ^a  

^a East Tennessee State University   (United States)

Author keywords

adrenergic receptor; 1 integrins; Apoptosis; Heart failure; JNK; MMPs

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA1 INTEGRIN; GELATINASE A; GELATINASE B; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STRESS ACTIVATED PROTEIN KINASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HYPERTENSION; ISOLATED HEART; KNOCKOUT MOUSE; M MODE ECHOCARDIOGRAPHY; MOUSE; NICK END LABELING; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; ECHOCARDIOGRAPHY; ECHOGRAPHY; ENZYMOLOGY; FIBROSIS; FORWARD HEART FAILURE; GENETICS; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHOSPHORYLATION; PRESSURE;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANTIGENS, CD29; APOPTOSIS; CARDIAC OUTPUT, LOW; ECHOCARDIOGRAPHY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROSIS; ISOPROTERENOL; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHOSPHORYLATION; PRESSURE; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 34047232485     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000258703.36986.13     Document Type: Article

References (41)

1. Singh K, Communal C, Sawyer DB, Colucci WS. Adrenergic regulation of myocardial apoptosis. Cardiovasc Res. 2000;45:713-719.
2. Fowler MB, Laser JA, Hopkins GL, Minobe W. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation. 1986;74:1290-1302.
3. Goldspink DF, Burniston JG, Ellison GM, Clark WA. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp Physiol. 2004;89:407-416.
4. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation. 1998;98:1329-1334.
5. Singh K, Xiao L, Remondino A, Sawyer DB. Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol. 2001;189:257-265.
6. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC. beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol. 1998;275:H961-H968.
7. Bos R, Mougenot N, Findji L, Mediani O. Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist. J Cardiovasc Pharmacol. 2005;45:8-13.
8. Stupack DG, Cheresh DA. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci. 2002;115:3729-3738.
9. Zhidkova NI, Belkin AM, Mayne R. Novel isoform of beta 1 integrin expressed in skeletal and cardiac muscle. Biochem Biophys Res Commun. 1995;214:279-285.
10. Communal C, Singh M, Menon B, Xie Z. β1 integrins expression in adult rat ventricular myocytes and its role in the regulation of beta-adrenergic receptor-stimulated apoptosis. J Cell Biochem. 2003;89:381-388.
11. Menon B, Singh M, Ross RS, Johnson JN. β-Adrenergic receptor-stimulated apoptosis in adult cardiac myocytes involves MMP-2-mediated disruption of beta1 integrin signaling and mitochondrial pathway. Am J Physiol Cell Physiol. 2006;290:C254-C261.
12. Menon B, Singh M, Singh K. Matrix metalloproteinases mediate beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes. Am J Physiol Cell Physiol. 2005;289:C168-C176.
13. Krishnamurthy P, Subramanian V, Singh M, Singh K. Deficiency of beta1 integrins results in increased myocardial dysfunction after myocardial infarction. Heart. 2006;92:1309-1315.
14. Stephens LE, Sutherland AE, Klimanskaya IV, Andrieux A. Deletion of beta 1 integrins in mice results in inner cell mass failure and periimplantation lethality. Genes Dev. 1995;9:1883-1895.
15. Friddle CJ, Koga T, Rubin EM, Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci U S A. 2000;97:6745-6750.
16. Kudej RK, Iwase M, Uechi M, Vatner DE. Effects of chronic beta-adrenergic receptor stimulation in mice. J Mol Cell Cardiol. 1997;29:2735-2746.
17. Trueblood NA, Xie Z, Communal C, Sam F. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res. 2001;88:1080-1087.
18. Menon B, Krishnamurthy P, Kaverina E, Johnson JN. Expression of the cytoplasmic domain of beta1 integrin induces apoptosis in adult rat ventricular myocytes (ARVM) via the involvement of caspase-8 and mitochondrial death pathway. Basic Res Cardiol. 2006;101:485-493.
19. Goldsmith EC, Carver W, McFadden A, Goldsmith JG. Integrin shedding as a mechanism of cellular adaptation during cardiac growth. Am J Physiol Heart Circ Physiol. 2003;284:H2227-H2234.
20. Baines CP, Molkentin JD. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol. 2005;38:47-62.
21. Ross RS, Pham C, Shai SY, Goldhaber JI. β1 integrins participate in the hypertrophic response of rat ventricular myocytes. Circ Res. 1998;82:1160-1172.
22. Brancaccio M, Fratta L, Notte A, Hirsch E. Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat Med. 2003;9:68-75.
23. Tan TP, Gao XM, Krawczyszyn M, Feng X. Assessment of cardiac function by echocardiography in conscious and anesthetized mice: importance of the autonomic nervous system and disease state. J Cardiovasc Pharmacol. 2003;42:182-190.
24. Takemoto Y, Yoshiyama M, Takeuchi K, Omura T. Increased JNK, AP-1 and NF-kappa B DNA binding activities in isoproterenol-induced cardiac remodeling. J Mol Cell Cardiol. 1999;31:2017-2030.
25. Iwase M, Bishop SP, Uechi M, Vatner DE. Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. Circ Res. 1996;78:517-524.
26. Shai SY, Harpf AE, Babbitt CJ, Jordan MC. Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res. 2002;90:458-464.
27. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet. 2006;367:356-367.
28. Ishigai Y, Mori T, Moriyama S, Shibano T. Induction of cardiac beta-adrenergic receptor kinase 1 in rat heart failure caused by coronary ligation. J Mol Cell Cardiol. 1999;31:1261-1268.
29. Prabhu SD, Chandrasekar B, Murray DR, Freeman GL. β-Adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation. 2000;101:2103-2109.
30. Hayakawa Y, Chandra M, Miao W, Shirani J. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation. 2003;108:3036-3041.
31. Mujumdar VS, Smiley LM, Tyagi SC. Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Int J Cardiol. 2001;79:277-286.
32. Mujumdar VS, Tyagi SC. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. J Hypertens. 1999;17:261-270.
33. Wang GY, Bergman MR, Nguyen AP, Turcato S. Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility. Cardiovasc Res. 2006;69:688-696.
34. Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol. 2003;285:H1229-H1235.
35. Remondino A, Kwon SH, Communal C, Pimentel DR. Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res. 2003;92:136-138.
36. Tyagi SC. Extracellular matrix dynamics in heart failure: a prospect for gene therapy. J Cell Biochem. 1998;68:403-410.
37. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD. Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem. 1991;266:7870-7875.
38. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem. 1995;270:5872-5876.
39. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4:197-250.
40. Matsusaka H, Ide T, Matsushima S, Ikeuchi M. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload. Hypertension. 2006;47:711-717.
41. Pozzi A, Moberg PE, Miles LA, Wagner S. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci U S A. 2000;97:2202-2207.